Effects of semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
Large observational studies have found that GLP-1 receptor agonists are associated with a lower risk of non-candida urinary tract infections compared to SGLT2 inhibitors, with a hazard ratio of 0.91 or lower and statistical significance below 0.001
These central effects are enhanced by the drugs ability to delay gastric emptying
If a patient is doing well on Mounjaro or Wegovy, tolerating the medication, and on a clear path toward their goal, switching to an oral GLP-1 to chase convenience rarely makes clinical sense
For women, its particularly effective for treating hypoactive sexual desire disorder (HSDD), a condition where sexual desire is persistently low